Momelotinib, sold under the brand name Ojjaara, is an anticancer medication used for the treatment of myelofibrosis. Reference standards of Momelotinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
No Data Found
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
